From: Case report: Candida krusei spondylitis in an immunocompromised patient
Reference | Species | Location | Sex/age | Symptoms and signs | Risk factors | Treatment | Results/follow-up |
---|---|---|---|---|---|---|---|
Kaldau et al., 2011 [8] | C. krusei and C. tropicalis | Feet | M/60 y | Pain, swell, leukocytoclastic vasculitis; BC positive | AB | IV Fluconazole and voriconazole 7 days, switch to AmB for 4 mo, relapse, multiple surgeries eventually amputation. | Resolved after relapse /12 months |
Peman et al., 2006 [3] | C. Krusei | Vertebra | M/62 y | Fever, myalgia, painful skin nodules; BC positive | AML, chemotherapy, neutropenia | IV AmB 2 weeks + caspofungin 4 wks followed by itraconazole PO 4 weeks. After relapse caspofungin + voriconazol 6 wks followed by voriconazol PO | Resolved after relapse/6 months |
Schilling et al., 2008 [4] | C. Krusei | Vertebra | M/58 y | Lumbar pain, fever; BC positive | AML, chemotherapy, neutropenia, AB | Voriconazole IV 9 days, switch to caspofungin due to ongoing fever for 14 days. Fosofomycin and rifampicin. After 4 mo surgery was performed, caspofungin reinitiated, after 1 mo posaconazole was added for a total of 1 y | Resolved/ 24 months |